Skip to main content

Table 1 Patient characteristics of all 35 patients with respect to primary tumor side, metastatic sites, number of metastatic sites and previous treatment as well as gender and age.

From: Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer

Characteristics

No.

No. Patients

35

Gender, male/female

25/10

median age, years (range)

62 (38–75)

Primary tumor site

 

Colon

21

Rectum

12

Ileum

1

Metastatic sites

 

Liver

26

Lung

12

Lymph nodes

6

Local relapse

3

other sites

3

Peritoneum

8

No. of metastatic sites

 

1

14

2

17

≥3

4

Previous treatment

 

surgery only

28

surgery+radiotherapy+adjuvant chemotherapy

1

surgery+adjuvant chemotherapy

5